Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Sorafenib Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Patented Drugs
  • 1.3.3 Generic Drugs
• 1.4 Market Segment by Application
  • 1.4.1 Global Sorafenib Market Share by Application (2019-2025)
  • 1.4.2 Kidney Cancer
  • 1.4.3 Liver Cancer
  • 1.4.4 Thyroid Cancer
  • 1.4.5 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Sorafenib Market Size
  • 2.1.1 Global Sorafenib Revenue 2014-2025
  • 2.1.2 Global Sorafenib Sales 2014-2025
• 2.2 Sorafenib Growth Rate by Regions
  • 2.2.1 Global Sorafenib Sales by Regions 2014-2019
  • 2.2.2 Global Sorafenib Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Sorafenib Sales by Manufacturers
  • 3.1.1 Sorafenib Sales by Manufacturers 2014-2019
  • 3.1.2 Sorafenib Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Sorafenib Revenue by Manufacturers (2014-2019)
  • 3.2.2 Sorafenib Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Sorafenib Market Concentration Ratio (CR5 and HHI)
• 3.3 Sorafenib Price by Manufacturers
• 3.4 Key Manufacturers Sorafenib Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Sorafenib Market
• 3.6 Key Manufacturers Sorafenib Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Patented Drugs Sales and Revenue (2014-2019)
  • 4.1.2 Generic Drugs Sales and Revenue (2014-2019)
• 4.2 Global Sorafenib Sales Market Share by Type
• 4.3 Global Sorafenib Revenue Market Share by Type
• 4.4 Sorafenib Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Sorafenib Sales by Application

6 United States

• 6.1 United States Sorafenib Breakdown Data by Company
• 6.2 United States Sorafenib Breakdown Data by Type
• 6.3 United States Sorafenib Breakdown Data by Application

7 European Union

• 7.1 European Union Sorafenib Breakdown Data by Company
• 7.2 European Union Sorafenib Breakdown Data by Type
• 7.3 European Union Sorafenib Breakdown Data by Application

8 China

• 8.1 China Sorafenib Breakdown Data by Company
• 8.2 China Sorafenib Breakdown Data by Type
• 8.3 China Sorafenib Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Sorafenib Breakdown Data by Company
• 9.2 Rest of World Sorafenib Breakdown Data by Type
• 9.3 Rest of World Sorafenib Breakdown Data by Application
• 9.4 Rest of World Sorafenib Breakdown Data by Countries
  • 9.4.1 Rest of World Sorafenib Sales by Countries
  • 9.4.2 Rest of World Sorafenib Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Bayer
  • 10.1.1 Bayer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Sorafenib
  • 10.1.4 Sorafenib Product Introduction
  • 10.1.5 Bayer Recent Development
• 10.2 Natco Pharma
  • 10.2.1 Natco Pharma Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Sorafenib
  • 10.2.4 Sorafenib Product Introduction
  • 10.2.5 Natco Pharma Recent Development
• 10.3 Cipla
  • 10.3.1 Cipla Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Sorafenib
  • 10.3.4 Sorafenib Product Introduction
  • 10.3.5 Cipla Recent Development
• 10.4 Mylan
  • 10.4.1 Mylan Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Sorafenib
  • 10.4.4 Sorafenib Product Introduction
  • 10.4.5 Mylan Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Sorafenib Sales Channels
  • 11.2.2 Sorafenib Distributors
• 11.3 Sorafenib Customers

12 Market Forecast

• 12.1 Global Sorafenib Sales and Revenue Forecast 2019-2025
• 12.2 Global Sorafenib Sales Forecast by Type
• 12.3 Global Sorafenib Sales Forecast by Application
• 12.4 Sorafenib Forecast by Regions
  • 12.4.1 Global Sorafenib Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Sorafenib Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Sorafenib is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sorafenib.

This report studies the global market size of Sorafenib, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Sorafenib sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Bayer
Natco Pharma
Cipla
Mylan
...

Market Segment by Product Type
Patented Drugs
Generic Drugs

Market Segment by Application
Kidney Cancer
Liver Cancer
Thyroid Cancer
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Sorafenib status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Sorafenib manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Sorafenib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025